PROM1 and melanoma: Following cell sorting and conditional reprogramming, CD133(+) cells exhibited higher invasion and metastasis, which is reversed by siRNA and CRISPR-Cas9 knockdown of CD133 in several patient-derived melanoma cell lines [17].